en Experimental Neurobiology

Cited by CrossRef (22)

  1. Taavi Vanaveski, Jane Narvik, Jürgen Innos, Mari-Anne Philips, Aigar Ottas, Mario Plaas, Liina Haring, Mihkel Zilmer, Eero Vasar. Repeated Administration of D-Amphetamine Induces Distinct Alterations in Behavior and Metabolite Levels in 129Sv and Bl6 Mouse Strains. Front. Neurosci. 2018;12
    https://doi.org/10.3389/fnins.2018.00399
  2. E. Leterme, W. De Troyer, L. Renier. Scopolamine als bestanddeel van een magistrale bereiding als zeldzame oorzaak van visuele hallucinaties. Tijdschr Geneesk 2021
    https://doi.org/10.47671/TVG.77.21.186
  3. Josh M. Krivinko, Jeremy Koppel, Alena Savonenko, Robert A. Sweet. Animal Models of Psychosis in Alzheimer Disease. The American Journal of Geriatric Psychiatry 2020;28:1
    https://doi.org/10.1016/j.jagp.2019.05.009
  4. Julie Berg, Gathi Abraham, Adelaide Robb, Finza Latif. Biochemical and Molecular Basis of Pediatric Disease. 2020.
    https://doi.org/10.1016/B978-0-12-817962-8.00033-0
  5. M. Carmen Arenas, Sergio Pujante-Gil, Carmen Manzanedo. Methods for Preclinical Research in Addiction. 2020.
    https://doi.org/10.1007/978-1-0716-1748-9_3
  6. Alessio Fiorentini, Filippo Cantù, Camilla Crisanti, Guido Cereda, Lucio Oldani, Paolo Brambilla. Substance-Induced Psychoses: An Updated Literature Review. Front. Psychiatry 2021;12
    https://doi.org/10.3389/fpsyt.2021.694863
  7. Chieh-Liang Huang, I-Ju Tsai, Cynthia Wei-Sheng Lee. Risk of psychosis in illicit amphetamine users: a 10 year retrospective cohort study. Evid Based Mental Health 2022:ebmental-2021-300300
    https://doi.org/10.1136/ebmental-2021-300300
  8. Christine L. Miller. The Epigenetics of Psychosis: A Structured Review with Representative Loci. Biomedicines 2022;10:561
    https://doi.org/10.3390/biomedicines10030561
  9. Po-An Chen, Hui-Yi Wang, Chien-Lun Sun, Mao-Liang Chen, Yi-Chyan Chen, Chih-Yuan Ko. Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice. Behavioural Neurology 2022;2022:1
    https://doi.org/10.1155/2022/1048463
  10. Tetsuo Ohnishi, Shabeesh Balan, Manabu Toyoshima, Motoko Maekawa, Hisako Ohba, Akiko Watanabe, Yoshimi Iwayama, Yuko Fujita, Yunfei Tan, Yasuko Hisano, Chie Shimamoto-Mitsuyama, Yayoi Nozaki, Kayoko Esaki, Atsuko Nagaoka, Junya Matsumoto, Mizuki Hino, Nobuko Mataga, Akiko Hayashi-Takagi, Kenji Hashimoto, Yasuto Kunii, Akiyoshi Kakita, Hirooki Yabe, Takeo Yoshikawa. Investigation of betaine as a novel psychotherapeutic for schizophrenia. EBioMedicine 2019;45:432
    https://doi.org/10.1016/j.ebiom.2019.05.062
  11. I. А. Fedotov, D. Quattrone, D. I. Shustov. Substance-induced psychosis and schizophrenia: the interaction point. I.P. Pavlov Russian Medical Biological Herald 2020;28:593
    https://doi.org/10.23888/PAVLOVJ2020284593-604
  12. L. Aparicio-Nava, L.A. Márquez-García, A. Meneses. Effects of 5-HT5A receptor blockade on amnesia or forgetting. Behavioural Brain Research 2019;357-358:98
    https://doi.org/10.1016/j.bbr.2018.01.009
  13. Weixuan Yao, Binjie Wang, Yuanzhao Wu, Jiye Wang, Zhongshi Xu, Fanwei Meng, Pengjuan Wang. Rapid Determination of Methamphetamine and Cocaine in Saliva by Portable Surface Plasmon Resonance (SPR). Analytical Letters 2022:1
    https://doi.org/10.1080/00032719.2022.2080839
  14. Michelle Cherro, Chonnakarn Jatchavala, DJibril I.M. Handuleh, Ramdas Ransing, Sheikh Shoib, Dorottya Őri, Margaret Isioma Ojeahere, Joan Soler-Vidal, Victor Pereira-Sanchez. Substance-induced or substance-associated primary psychoses? Continuing the discussion. A response to I.А. Fedotov, et al. I.P. Pavlov Russian Medical Biological Herald 2021;29:171
    https://doi.org/10.23888/PAVLOVJ2021291171-176
  15. Kinga Gawel, Nancy Saana Banono, Agnieszka Michalak, Camila V. Esguerra. A critical review of zebrafish schizophrenia models: Time for validation?. Neuroscience & Biobehavioral Reviews 2019;107:6
    https://doi.org/10.1016/j.neubiorev.2019.08.001
  16. Serge Weis, Michael Sonnberger, Andreas Dunzinger, Eva Voglmayr, Martin Aichholzer, Raimund Kleiser, Peter Strasser. Imaging Brain Diseases. 2019.
    https://doi.org/10.1007/978-3-7091-1544-2_50
  17. Stefania Schiavone, Luigia Trabace. The use of antioxidant compounds in the treatment of first psychotic episode: Highlights from preclinical studies. CNS Neurosci Ther 2018;24:465
    https://doi.org/10.1111/cns.12847
  18. Wenji He, Xinyu Yan, Sanqiang Pan. Amphetamine Neurotoxicity in PC12 Cells through the PP2A/AKT/GSK3β Pathway. Neurotox Res 2018;34:233
    https://doi.org/10.1007/s12640-018-9880-8
  19. So Hyeon Park, Yoo Sung Song, Byung Seok Moon, Byung Chul Lee, Hyun Soo Park, Sang Eun Kim. Combination of In Vivo [123I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum. Exp Neurobiol 2019;28:602
    https://doi.org/10.5607/en.2019.28.5.602
  20. Marco Colizzi, Sagnik Bhattacharyya. Risk Factors for Psychosis. 2019.
    https://doi.org/10.1016/B978-0-12-813201-2.00016-8
  21. Kelsey S. Hideshima, Ashkhan Hojati, Justin M. Saunders, Doan M. On, Mario de la Fuente Revenga, Jong M. Shin, Ana Sánchez-González, Cassandra M. Dunn, Alexander B. Pais, Anthony C. Pais, Michael F. Miles, Jennifer T. Wolstenholme, Javier González-Maeso. Role of mGlu2 in the 5-HT2A receptor-dependent antipsychotic activity of clozapine in mice. Psychopharmacology 2018;235:3149
    https://doi.org/10.1007/s00213-018-5015-4
  22. Anton M. Lakstygal, Tatiana O. Kolesnikova, Sergey L. Khatsko, Konstantin N. Zabegalov, Andrey D. Volgin, Konstantin A. Demin, Vadim A. Shevyrin, Edina A. Wappler-Guzzetta, Allan V. Kalueff. DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens. ACS Chem. Neurosci. 2019;10:2144
    https://doi.org/10.1021/acschemneuro.8b00615